Solsys Medical’s TheraSkin Regenerative Wound Healing

     Product Chosen to be a Part of Healogics New iSupply(SM) Program


NEWPORT NEWS, Va.Sept. 10, 2018 /PRNewswire/ — Solsys Medical, LLC (“Solsys”) (formerly known and doing business as Soluble Systems, LLC) (“Solsys Medical”), which markets TheraSkin®, a cellular and tissue-based product for regenerative wound healing, announced today that it has partnered with Healogics, the nations largest provider of advanced chronic wound care services, to be a part of the new Healogics iSupply program, offering TheraSkin to Healogics facilities. Through the partnership with Healogics, Solsys furthers its mission to improve quality outcomes while reducing the total cost of care.  TheraSkin is a living human split-thickness skin allograft that is cryopreserved to preserve living cells and growth factors while maintaining a mature native human dermal architecture.  The versatility in applications and sizes of TheraSkin reduces product waste and helps to drive operational efficiencies in the wound care center to better manage total cost of care and quality outcomes related to wound care.


“We are very excited to be working with Healogics and have TheraSkin included in its iSupply initiative,” stated Allan Staley, CEO of Solsys Medical. “The iSupply program enables Healogics’ hospital partners improved access to TheraSkin in order to improve wound healing outcomes at a lower cost.” … read more